181 related articles for article (PubMed ID: 9411357)
1. [Malignant mesothelioma of the pleura. Morphometric study].
Serio G; Caniglia DM; Pennella A; Giardina C; Dalena AM; Serio R; Lettini T; Ricco R
Pathologica; 1997 Apr; 89(2):122-7. PubMed ID: 9411357
[TBL] [Abstract][Full Text] [Related]
2. Benign and malignant mesothelial lesions of the pleura: quantitative study.
Ranaldi R; Marinelli F; Barbatelli G; Mariuzzi G; Marzocchi F; Mancini AM; Pisani E; Ansuini G; Ricci M
Appl Pathol; 1986; 4(1-2):55-64. PubMed ID: 3580194
[TBL] [Abstract][Full Text] [Related]
3. Computerized interactive morphometry. A study of malignant mesothelioma and mesothelial hyperplasia in pleural biopsy specimens.
Marchevsky AM; Gil J; Caccamo D
Arch Pathol Lab Med; 1985 Dec; 109(12):1102-5. PubMed ID: 3840984
[TBL] [Abstract][Full Text] [Related]
4. Value of morphometry, texture analysis, densitometry, and histometry in the differential diagnosis and prognosis of malignant mesothelioma.
Weyn B; Van De Wouwer G; Koprowski M; Van Daele A; Dhaene K; Scheunders P; Jacob W; Van Marck E
J Pathol; 1999 Dec; 189(4):581-9. PubMed ID: 10629562
[TBL] [Abstract][Full Text] [Related]
5. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
Cakir E; Demirag F; Aydin M; Unsal E
Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
[TBL] [Abstract][Full Text] [Related]
6. My approach to the diagnosis of mesothelial lesions.
Butnor KJ
J Clin Pathol; 2006 Jun; 59(6):564-74. PubMed ID: 16731600
[TBL] [Abstract][Full Text] [Related]
7. Quantitative ultrastructural study of nuclei from exfoliated benign and malignant mesothelial cells and metastatic adenocarcinoma cells.
Dardick I; Butler EB; Dardick AM
Acta Cytol; 1986; 30(4):379-84. PubMed ID: 3461648
[TBL] [Abstract][Full Text] [Related]
8. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
9. The significance of morphometric methods in cytologic diagnostics: differentiation between mesothelial cells, mesothelioma cells and metastatic adenocarcinoma cells in pleural effusions with special emphasis on chromatin texture.
Oberholzer M; Ettlin R; Christen H; Gschwind R; Buser M; Rösel F; Lötscher R; Dalquen P
Anal Cell Pathol; 1991 Jan; 3(1):25-42. PubMed ID: 2001333
[TBL] [Abstract][Full Text] [Related]
10. A morphometrically-based classification rule for the diagnosis of primary mesothelial lesions.
Robutti F; Betta PG; Donna A; Pavesi M
J Pathol; 1990 Sep; 162(1):57-60. PubMed ID: 2231194
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between primary pleural and primary peritoneal mesotheliomas by morphometry and analysis of the vacuolization pattern of the exfoliated mesothelial cells.
Boon ME; Kwee HS; Alons CL; Morawetz F; Veldhuizen RW
Acta Cytol; 1982; 26(2):103-8. PubMed ID: 6952709
[TBL] [Abstract][Full Text] [Related]
12. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
Cury PM; Butcher DN; Corrin B; Nicholson AG
J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
[TBL] [Abstract][Full Text] [Related]
13. Stereological evaluation of malignant mesothelioma versus benign pleural hyperplasia.
Bogers J; Jacobs W; Segers K; Van Daele A; Weyler J; Van Marck E
Pathol Res Pract; 1996 Jan; 192(1):10-4. PubMed ID: 8685035
[TBL] [Abstract][Full Text] [Related]
14. Digital image analysis in cytological diagnosis: a morphometric analysis on pleural mesotheliomas.
Christen H; Oberholzer M; Buser M; Lötscher R; Gschwind R; Rösel F; Ettlin R; Feess A; Dalquen P
Anal Cell Pathol; 1989 Apr; 1(2):105-22. PubMed ID: 2487514
[TBL] [Abstract][Full Text] [Related]
15. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
Soosay GN; Griffiths M; Papadaki L; Happerfield L; Bobrow L
J Pathol; 1991 Apr; 163(4):299-305. PubMed ID: 2033489
[TBL] [Abstract][Full Text] [Related]
16. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
17. [Pleural mesothelioma: morphology, histochemistry, difficulties in diagnosis and nosologic problems (author's transl)].
Abelanet R; Jagueux M; Fondimare A; Roujeau J
Rev Fr Mal Respir; 1979; 7(3):243-64. PubMed ID: 91185
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of pleural malignant mesothelioma in life--a practical approach.
Whitaker D; Shilkin KB
J Pathol; 1984 Jul; 143(3):147-75. PubMed ID: 6379132
[TBL] [Abstract][Full Text] [Related]
19. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
[TBL] [Abstract][Full Text] [Related]
20. The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies.
Galloway ML; Murray D; Moffat DF
Histopathology; 2006 May; 48(6):767-9. PubMed ID: 16681698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
